Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$18,696→$04 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CDIO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 14.6%
Operating cash flow changed +14.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$1.6M→-$1.3M4 prior comparisons
Operating margin moved 549299 bp lower
Operating margin changed -549299 basis points from the comparable as-filed period.
-22457.51%→-27950.50%3 prior comparisons
Free-cash-flow proxy increased 15.6%
Free-cash-flow proxy changed +15.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$1.6M→-$1.3M4 prior comparisons
Revenue decreased 28.3%
Revenue changed -28.3% from the comparable as-filed period.
$7,475→$5,3603 prior comparisons
SBC / revenue moved 4258 bp higher
SBC / revenue changed +4258 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
411.75%→454.33%3 prior comparisons
Trade receivables decreased 69.8%
Trade receivables changed -69.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$12,927→$3,9054 prior comparisons
Working capital decreased 30.4%
Working capital changed -30.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$8.3M→$5.8M4 prior comparisons
Current assets decreased 29.2%
Current assets changed -29.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$8.7M→$6.2M4 prior comparisons
Shares outstanding increased 67.9%
Shares outstanding changed +67.9% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
1,763,129→2,959,4698 prior comparisons
Capex / revenue moved 25011 bp lower
Capex / revenue changed -25011 basis points from the comparable as-filed period.
250.11%→0.00%3 prior comparisons
Receivables / revenue moved 10008 bp lower
Receivables / revenue changed -10008 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
172.94%→72.85%3 prior comparisons
Operating income increased 10.8%
Operating income changed +10.8% from the comparable as-filed period.
-$1.7M→-$1.5M3 prior comparisons
Total assets decreased 23.8%
Total assets changed -23.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$10.4M→$7.9M4 prior comparisons
Stock-based compensation decreased 20.9%
Stock-based compensation changed -20.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$30,778→$24,3524 prior comparisons
Working capital / assets moved 697 bp lower
Working capital / assets changed -697 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
80.16%→73.19%4 prior comparisons
Free-cash-flow margin moved 377105 bp lower
Free-cash-flow margin changed -377105 basis points from the comparable as-filed period.
-21273.06%→-25044.10%3 prior comparisons
Operating cash-flow margin moved 402116 bp lower
Operating cash-flow margin changed -402116 basis points from the comparable as-filed period.
-21022.94%→-25044.10%3 prior comparisons
R&D / revenue moved 85783 bp higher
R&D / revenue changed +85783 basis points from the comparable as-filed period.
2181.89%→3039.72%3 prior comparisons
Current ratio decreased 27.2%
Current ratio changed -27.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
23.55→17.154 prior comparisons
Current liabilities decreased 2.8%
Current liabilities changed -2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$369,597→$359,1974 prior comparisons
Research & development decreased 0.1%
Research & development changed -0.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$163,096→$162,9293 prior comparisons
Cash & equivalents changed across a zero base
Cash & equivalents changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$00 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.